<DOC>
	<DOC>NCT00517426</DOC>
	<brief_summary>To evaluate the effects of CO2 inhalation and acetazolamide treatment on exercise-induced periodic breathing in patients with chronic stable heart failure. Patients will be given CO2 (2%) during a constant workload exercise. Patients will be also evaluated by maximal cardiopulmonary exercise test without and with acetazolamide acute and chronic treatment.</brief_summary>
	<brief_title>Effects of Acetazolamide and CO2 Inhalation on Exercise-induced Periodic Breathing in Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Acetazolamide</mesh_term>
	<criteria>chronic heart failure in stable clinical condition exerciseinduced periodic breathing comorbidities NYHA class IV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>heart failure,</keyword>
	<keyword>exercise</keyword>
	<keyword>periodic breathing,</keyword>
	<keyword>acetazolamide</keyword>
</DOC>